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Craniofacial area represent a unique district of human body characterized by a very
high complexity of tissues, innervation and vascularization, and being deputed to many
fundamental function such as eating, speech, expression of emotions, delivery of
sensations such as taste, sight, and earing. For this reasons, tissue loss in this area
following trauma or for example oncologic resection, have a tremendous impact on
patients’ quality of life. In the last 20 years regenerative medicine has emerged as one of
themost promising approach to solve problem related to trauma, tissue loss, organ failure
etc. One of the most powerful tools to be used for tissue regeneration is represented
by stem cells, which have been successfully implanted in different tissue/organs with
exciting results. Nevertheless, both autologous and allogeneic stem cell transplantation
raise many practical and ethical concerns that make this approach very difficult to apply
in clinical practice. For this reason different cell free approaches have been developed
aiming to the mobilization, recruitment, and activation of endogenous stem cells into
the injury site avoiding exogenous cells implant but instead stimulating patients’ own
stem cells to repair the lesion. To this aim many strategies have been used including
functionalized bioscaffold, controlled release of stem cell chemoattractants, growth
factors, BMPs, Platelet–Rich-Plasma, and other new strategies such as ultrasound wave
and laser are just being proposed. Here we review all the current and new strategies used
for activation andmobilization of endogenous stem cells in the regeneration of craniofacial
tissue.
Keywords: craniofacial abnormalities, regenerative medicine, stem cell transplantation, stem cells and
regenerative medicine, stem cells recruitment, SDF1, bioscaffold, BMP signaling
INTRODUCTION
Regenerative medicine is the field of translational research that aims to replace and repair cells,
tissues and organs to restore their normal functions (Mason and Dunnill, 2008). In the last 20
years, the possibility to use endogenous and exogenous stem cells for tissue repair has emerged
producing enthusiasm in the scientific and medical community, but on the other side, raising a
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series of ethical and practical issues. The craniomaxillofacial
complex is of fundamental importance for many different
functions, such as breathing and eating, others non-vital but
still important for social relationships, such as aesthetics and
the delivery of senses such as sight, smell, and sound. For
these reasons, craniomaxillofacial tissue damages have serious
physiological and psychological consequences, and it is of
paramount importance to seek solutions to optimize the life
of people with maxillofacial trauma (Teo and Vallier, 2010).
Many disciplines, such as biology, medicine, chemistry, and
engineering, are involved in the study and development of
techniques or products that regenerate the native conditions
of such a complicated body region as the craniofacial tissues
such as bone, muscle, cartilage and nervous tissue. The research
moved toward two main different directions: one that involves
the study of stem cell biology, including the development of novel
techniques to isolate, characterize and transplant stem cells, the
other related to the material science, which aims to the creation
of new biomaterials and technologies suitable for the use with
stem cells. As for stem cell biology, the research focused on stem
and progenitor cells isolation, characterization, expansion, and
transplantation for replacing damaged tissues (Giuliani et al.,
2013) and on the study of growth-factors and genetic technology
to control proliferation, migration and ability in tissue repair and
regeneration (Alvarez et al., 2012; Han et al., 2014).
Many types of stem/progenitor cells have been described
and proposed for their ability to rescue and repair injured
tissue and partially restore organ function. Stem cells are
undifferentiated cells capable to undergo an indefinite number of
replications (self-renewal) and give rise to progenitor and finally
to specialized cells. Therefore, stem cells differ from other types
of cells in the body because they are capable of sustaining self-
renewal, are unspecialized, and can give rise to differentiated
cell types (La Noce et al., 2014a). In the field of regenerative
medicine, two main types of stem cells are used: Embryonic
stem cells (ESCs) and Adult stem cells (ASCs). The embryonic
stem cells are isolated from the inner cell mass (ICM) of the
blastocyst, they are able to differentiate in all the tissues deriving
from the three definitive germ layers, and for this reason they
are considered “pluripotent.” Adult stem cells reside in the
adult tissues and they are pivotal for the tissue homeostasis
(Mohanty et al., 2015); unlike ESCs, these cells are only able
to differentiate into a limited group of cells types, and they are
considered “multipotent.” In the recent years a new source of
stem cells for regenerative and translational medicine has been
created by transfecting adult cells (mainly dermal fibroblasts)
with a varying number of stem-associated genes producing the
so-called induced Pluripotent Stem Cells (iPSCs) (Takahashi et al.,
2007). In this review, only Adult Stem Cells (ASCs) or cell-
free approaches in regenerative medicine will be considered.
Today, multiple sources for the isolation of adult stem cells
have been identified, including heart tissue (Warejcka et al.,
1996), umbilical cord blood (Campagnoli et al., 2001), skeletal
muscle (Wada et al., 2002), and the dermis of skin (Toma et al.,
2001). To identify a suitable cell population for craniofacial
regeneration, many odontogenic stem cells, including dental
pulp stem cells (Gronthos et al., 2000; Laino et al., 2005;
d’Aquino et al., 2007, 2011), periodontal ligament stem cells
(Seo et al., 2004), stem cells from human exfoliated deciduous
teeth (Cordeiro et al., 2008), and stem cells from apical papilla
(Sonoyama et al., 2008) and some non-odontogenic stem cells,
including adipose-derived stem cells (Hung et al., 2011), bone
marrow mesenchymal stem cells (Li et al., 2007), gingival stem
cells (Hakkinen et al., 2014), embryonic stem cells (Ohazama
et al., 2004), neural crest cells (Jiang et al., 2008), and even
hair follicle stem cells (Wu et al., 2009) have been selected
for screening. Studies have demonstrated that all odontogenic
stem cells have a certain degree of multipotency in vitro and
form pulp-dentin complexes combined with scaffold materials in
vivo, except for PDLSCs, which tend to form bone-like tissues
in vivo (Mangano et al., 2011; La Noce et al., 2014b; Naddeo
et al., 2015). In contrast, non-odontogenic stem cells other than
BMSCs have not yet been confirmed to have the potential for
tooth regeneration. Among these cell types, postnatal DPSCs
have the most potential as stem cells for endodontic tissue
regeneration (Gronthos et al., 2002; Nakashima et al., 2004,
2009; Laino et al., 2005; Murray et al., 2007; Mangano et al.,
2011; Paino et al., 2014; Naddeo et al., 2015). Nevertheless
there is the need for craniofacial regeneration to repair tissue
such as bone and soft tissue such as adipose tissue and among
the different sources of stem cells bone marrow and adipose
tissue seem to be the most promising. For what concerns
material science, this constitutes one of the subjects most widely
studied in recent years for its application in many fields of
medicine, such as tissue engineering and regenerative medicine.
The real paradigm shift that took place in the last years is the
overlap of the material science with the biology, in an attempt
to create new materials—also defined as smart materials or
biomaterials—that do not only exist as passive support to living
cells, but that are also able to interact and respond sensitively
to environmental cues derived from these cells (Mangano et al.,
2011). Moreover, the increasing understanding of the natural
mechanisms involved in the development of tissues and organs
has led to the creation of three-dimensional in vitro bioreactors,
including nanotechnology and microfluidics-based bioreactors
that recapitulate normal and pathological tissue development,
structure and function (Rajan et al., 2014; Obregon et al.,
2015) and pave the way to the idea of “printed organ,” a new
technique used for fabrication of organ-like constructs (Choi and
Kim, 2015; Ledford, 2015). These technologies have been made
possible thanks to the mind-shift that has brought scientists to
create synthetic matrices that recapitulate the natural properties
of the extracellular matrix (ECM) of the different tissues, as a
direct consequence of the evidences that the composition of the
scaffold is able to influence stem cell proliferation, differentiation
and angiogenesis through integrin signaling (Pittenger et al.,
1999; Hynes, 2002a,b).
GRAFTING APPROACHES
In last years scientific findings highlighted the importance of
human cell therapy. In regenerative medicine stem cells can be
used from donor that is a family member (allogeneic by family),
donor unrelated (allogeneic cells from unrelated volunteer)
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or the patient’s own (autologous). Stem cell commonly used
in the therapy for craniofacial region are bone marrow stem
cells(Yang et al., 2014), adipose stem cells (Griffin et al., 2014)
hematopoietic stem cell (Vesterbacka et al., 2012) dental pulp
stem cells (Giuliani et al., 2013). Both allogeneic and autologous
cell therapies may be subdivided into two types: cell therapy
for acute or for chronic conditions, the first to limit the natural
progression of disease, the second for full regeneration (Sadan
et al., 2008; Carpenter et al., 2009). Those approaches can be
exploited in many clinical situations; therefore it is important
that advantages and disadvantages of both therapies are made
clear.
Allogeneic Stem Cells Transplant
Pros
Allogeneic cells represent a therapeutic technology that fits
easily in pharmaceutical production. So it is more efficient
to produce cells from multiple patients and introduce them
into a conventional quality control (QC) system, where it is
ascertained the safety of the product and its characterization
from the biological point of view. As autologous cells, allogeneic
cells are expandable in culture, thus allowing the production of
numerous batches of material and therefore their distribution
on a large scale. This represents a great potential for economic
development, promoting the improvement and expansion of this
therapy (Mason and Dunnill, 2008). In medical emergencies the
allogeneic cells havemany advantages due to the rapid availability
of these cells, which guarantee a good stability during storage
and already occurred characterization. It is also not necessary to
perform a biopsy on a person potentially sick, avoiding additional
stress to the patient and saving time.
Cons
The most common problem in allogeneic cell transplantation
is related to the host immune response that, directed against
grafted cells, can lead to strong inflammatory reaction and
consequent destruction of the graft (Barker and Widner, 2004).
Nevertheless, some types of stem cells as MSCs have shown
immunomodulatory activity in some autoimmune disorders,
such as graft-versus-host disease and systemic lupus (Sui et al.,
2013; Zhao et al., 2015), but this feature seem to not be sufficient
or to not apply to grafted stem cells. In fact different strategies
have been proposed to overcome this problem as discussed by
Guha et al. (2013). Another major problem arising with allograft
is the risk of generating tumors in the host. Transplanted cells
can trigger a mechanism of crosstalk with the microenvironment
of the receiver, which, combined with the stem cells growth
capacity, brings along the risk of uncontrolled growth after
transplantation. As an example Amariglio et al. described the
generation of brain benign tumor after stem cells transplantation
in a patient affected by ataxia telangiectasia (Amariglio et al.,
2009). This problem can also be explained by the fact that in vitro
expanded stem cells bring increased genetic abnormalities, which
can favor cancer initiation (Spits et al., 2008). In fact, before use
for allogeneic transplantation, stem cells are extensively cultured,
and the accumulation of genomic abnormalities may represent a
risk to the recipient. Another issue in derivation and culturing
stem cells for allogeneic transplantation is the use of animal
products in cell culture (Foetal Bovine Serum for instance),
increasing risk of graft rejection and transmission of zoonosis
(Chavez et al., 2008).
Autologous Stem Cells Transplantation
Pros
The greatest advantage in the use of autologous cells is
definitely to avoid immunological responses host-versus-graft.
Furthermore during therapy with autologous cells you can
prevent the immunosuppressive treatment on the patient,
avoiding the risk of infections and lowering by far the costs of the
therapy (Chen and Palmer, 2008). In bioaesthetic treatment this
approach seems to bemost suitable for the less intrusive therapies
and look more natural given by the patient’s own cells (Tsai
et al., 2000). In the autograft, the cells used are isolated from the
donor-patient and when the number of cells obtained by biopsy
is sufficient for transplantation it is not necessary to amplify,
avoiding the anomalies due to an excessive growth in vitro (Baker
et al., 2007). In addition, they are not exposed to products of
animal origin, removing from the risk of zoonosis. Finally, the
patient-derived cells do not incur ethical battles and regulation,
therefore their use is much simpler than that of allografts.
Cons
One of the major issues concerning the autograft is the limitation
of material to engage in certain patients, such as children under
6 years of age or with particular diseases (Smith et al., 2011). In
addition, craniofacial reconstruction may be even more difficult
in the pediatric patient because the skull is not developed enough
so the split-thickness bone grafting is not tolerated (Chenard
et al., 2012).
Another complication is the side effects that occur in the
donor site, which involves hematoma, infection, nerve damage,
bone pain and fractures. All this may adversely affect the
treatment and increase the length of hospital stay (Seiler et al.,
2000; Smith et al., 2008). Moreover, the cells obtained by biopsy
may not be sufficient for the graft, this involves an in vitro
expansion, time consuming and often not successful. For all these
reasons, this approach is not be used in emergency situations.
The material used must be processed separately for each patient
with customized protocols using the patient’s own serum. For this
reasons the use on a large scale is hardly feasible for the costs and
the time required by each therapy.
ENDOGENOUS STEM CELLS: CURRENT
APPROACHES
The ultimate goal in the stem cell field is to find a way
to translate our growing body of knowledge on stem cell
biology into therapeutic applications for regenerative medicine.
In that regard, most of our attention has focused upon stem-
cell transplantation approaches, which have been considered
above. On the other hand, the need to overcome the drawbacks
associated with these approaches (mainly, the necessity of
manipulating the cells before the graft takes place) has led to
the development of new strategies to achieve tissue repair. The
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finding that many adult tissues contain stem cells that function to
maintain and repair tissue damage (Su et al., 2009) paved the way
to the idea that we could somehow recruit these endogenous stem
cells in order to enhance tissue regeneration. Moreover, whereas
the grafting strategies require the exogenous activation of stem
cells, an endogenous re-activation can be speculated without the
need of isolation, manipulation and grafting (Miller and Kaplan,
2012). However, though the concept of adult stem cells is an
old one, the idea of their exploitation for regenerative purposes
has gained attention only in the last few years. This is mainly
due to the experimental evidence coming from studies showing
that tissue stem cell behavior can be modulated differentially in
physiologic and pathologic settings both in the animal model
and in the human. For example, it is now well-established that
regular exercise and brain injury can enhance neurogenesis,
precursor proliferation and oligodendrogenesis in rodents (Ming
and Song, 2011) and these results are comparable to those from
recent imaging studies that show how aerobic exercise training
enhances hippocampal volume in elderly humans (Erickson
et al., 2011, 2012). Another reason we are currently approaching
the idea of manipulating resident stem cells is that we now
know that in some cases the factors that induce the stem cell
response are the same that we have studied in other contexts,
e.g., the growth factor BDNF is required for exercise-induced
neurogenesis (Ming and Song, 2011). Moreover, a number
of growth factors that were originally identified in stem cell
culture studies have been shown to activate stem cells in vivo
(Mitchell et al., 2004). We will now focus on the different
approaches that have stemmed in regenerative medicine from
the above considerations, with a special focus on craniofacial
regeneration.
Scaffolds in Bone Regeneration
Understanding that the three-dimensional (3D) structure of the
extracellular matrix (ECM) is integral for tissue formation and
regeneration has led researchers to make an effort to recreate this
environment when attempting to repair tissue defects, creating
biocompatible matrices known as scaffolds. A scaffold is a
three-dimension biomaterial designed to allow cell-biomaterial
interactions, cell survival, proliferation and differentiation. That
scaffold can be designed to biodegrade at a controllable rate and
is characterized by a low degree of toxicity in vivo. Whether
produced using synthetic or biologic materials, scaffold matrices
enhance tissue growth and repair by facilitating delivery and
localization of progenitor cells and growth factors to a desired
location (Dhandayuthapani et al., 2011). Historically, scaffolds
have been used as delivery systems in cell-based applications,
whereas their use in cell-free strategies for tissue regeneration is
relatively new (Bueno and Glowacki, 2009).
The use of scaffolds that accurately reproduce the structure of
the native ECM (the so-called biomimetic scaffolds) is particularly
useful in cranio-facial bone defects, as they play the role
of template analogous for complex anatomical form while
minimizing supply constraints. These types of scaffold vary in
pore size, mechanical properties and degree of biodegrability,
according to their chemical structure (Teven et al., 2015; see
Table 1).
Though a large amount of evidence correlates bioscaffold
to increased tissue regeneration, it is still not clear whether
this effect can be explained by the activation of endogenous
stem cells (Zaky and Cancedda, 2009). For this reason, in the
practice, scaffold-based approaches are generally combined with
cell- and/or growth factor-based approaches. The former have
already been discussed above (see section above), while the latter
will be now presented.
Growth-Factors-Mediated Activation
and/or Mobilization of Stem Cells
Since several studies demonstrated the role of growth factors in
stem cell biology (reviewed in Brizzi et al., 2012), it is almost
impossible to ignore their potential provision to the therapeutic
goal of tissue regeneration. Wagers previously reviewed how the
use of growth factors in the clinic has already led to successful
therapies in hematology and orthopedics (respectively, G-CSF
analogs for chemotherapy-related neutropenia and parathyroid
hormone analogs for osteoporosis; Wagers, 2012). In both these
conditions, the support given to the stem cells is systemic, as
it works in a tissue-specific fashion, with no privileged site of
action. This is not the case in regenerative medicine, where the
regeneration is usually desired only in a limited subset of body
locations. For this reason, local delivery of growth factors to
the site of lesion is a more suitable approach in regenerative
medicine, and is usually pursued by binding growth factors to
scaffolds (Figure 1). Depending on the desired release kinetic,
growth factors can be either directly adsorbed to scaffolds or
encapsulated in microspheres, respectively for a burst release
or a sustained and delayed release. As for bone regeneration,
which is the most investigated field in regenerative medicine
of the craniofacial district, several growth factors have been
identified with a wide range of activities in vivo (see Table 2).
Bone morphogenetic proteins (BMPs) are a family of growth
factors involved in embryonic development and regeneration
of mesenchymal tissues (Zhao, 2003), whose roles have been
investigated thoroughly in bone biology (reviewed in Luu et al.,
2007). Although many isoforms of BMPs are known, only a
small subset has been shown to be active in in vivo models of
bone defects. BMP-2, among the others, is lethal in knockout
mice model and was associated to orofacial clefting in case of
haploinsufficiency in humans (Zhang and Bradley, 1996; Sahoo
et al., 2011); for this reason, its use has been suggested for
craniofacial bone reconstruction (Chenard et al., 2012). BMP-7
showed superior bone induction compared to autologous bone
graft in an animal model of calvarial defect, when injected locally
(Springer et al., 2005a,b). BMP-7 is also able to determine a
widespread skeletal regeneration, and this led to its approval
for use, along with BMP-2, in case of non-unions and open
fractures of long bones (Gautschi et al., 2007). Other BMPs
lack evidence of clinical relevance and their possible roles in
the practice are reviewed by Bessa et al. (2008a,b). If, on
one hand, BMPs support bone regeneration by activation of
perilesional osteoprogenitor cells, several different growth factors
can be used to stimulate mobilization of nearby or distant stem
cells and their homing to the defect site (Herrmann et al.,
2015).
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TABLE 1 | Most used biomimetic scaffolds for cranio-facial bone regeneration in cell-based and cell-free applications.
Scaffold name Chemical structure Features and uses Reference(s)
Polymer-based scaffolds
NATURAL POLYMERS
Chitosan Deacetylated derivative of chitin Highly hydrophilic, osteoconductive in vitro and in
vivo but not reliable for load bearing applications.
Muzzarelli et al., 1994; Seol
et al., 2004
Fibroin Insoluble protein from silk High mechanical strength and biodegradability.
Highly customizable processing (gels, sponges,
nets), but lower osteoconductivity.
Riccio et al., 2012; Panda
et al., 2015
Collagen Fibrillar collagen Highly biodegradable and osteoconductive. High
osteoconductivity, but not reliable for load bearing
applications.
Ferreira et al., 2012
SYNTHETIC POLYMERS
Poly(lactic-co-glycolic acid) (PLGA) Poly(α-hydroxy esters) constituted of
a combination of poly(lactic acid)
(PLA) and poly(glycolic acid) (PGA)
Different combinations of the two components
lead to highly customizable degradation rate,
mechanical properties and osteoconductivity.
Lin et al., 2002; Gentile
et al., 2014; Liu et al., 2014
Poly(e-caprolactone) (PCL) Aliphatic polyester Long degradation time and scarce ability to
mediate cellular adhesion. Useful for the
production of Shape-Memory Polymers (SMPs).
Schantz et al., 2003a,b;
Zhang et al., 2014
CALCIUM PHOSPHATE-BASED CERAMIC SCAFFOLDS
Hydroxyapatite (HA) Ca10(PO4)6(OH)2 (Inorganic phase
of native bone)
Highly biocompatible and osteoconductive. Slow
rate of degradation, affected by crystallinity.
Suitable for load-bearing applications.
Yoshikawa and Myoui,
2005; Bose et al., 2012
β-tricalcium phosphate (β-TCP) Ca3(PO4)2 Highly biocompatible and osteoconductive. Very
brittle.
Rezwan et al., 2006;
Kamitakahara et al., 2008
Amorphous Calcium Phosphate (ACP) Ca3n(PO4)2n Highly biocompatible and osteoconductive.
Degradation through a process of
dissolution-precipitation to form HA.
Kobayashi et al., 2014
Biphasic calcium phosphate (BCP) Combination of HA and β-TCP Highly biocompatible and osteoconductive.
Porosity and grain size highly customizable. The
addition of zinc or silicone oxide confers an
increase in compressive strength and
angiogenesis.
Tevlin et al., 2014
COMPOSITE SCAFFOLDS
Polymer-calcium phosphate composites Addition of Ca-P nanoparticles to
polymer-based scaffolds
(e.g.chitosan or fibroin)
Higher biocompatibility compared to polymer-only
scaffolds and improved compressive strength
compared to ceramic-only scaffolds. Superior
bone growth in in vivo calvarial defect model.
Chesnutt et al., 2009; Qi
et al., 2014
Poly(lactic acid)-calcium phosphate and
poly(glycolic acid)-calcium phosphate
PLA, PGA or PLGA scaffolds added
with HA
Increased compression modulus and tensile
strength compared to PLGA scaffolds. Increased
de novo bone formation.
Kim et al., 2006; Yoon et al.,
2007
Poly(e-caprolactone)- calcium phosphate
composites
PCL added with TCP Less hydrophobic than PCL alone and increased
compressive strength compared to TCP alone.
Suitable for load-bearing applications and
osteogenic differentiation of stem cells.
Liao et al., 2013; Baykan
et al., 2014
Poly(1,8-octanediol-co citric acid) (POC) Citric acid-based elastomer
combined with HA and TCP
Highly biocompatible and osteoconductive. Citric
acid released during polymer degradation
regulates apatite nanocrystals growth, increasing
stability, strength, and resistance to fracture.
Chung et al., 2011; Costello
et al., 2012; Davies et al.,
2014
Vascular Endothelial Growth Factor (VEGF) is most known
for its role in angiogenesis, but has also revealed a direct
involvement in supporting bone formation (Schipani et al.,
2009): for this reason, numerous preclinical bone healing models
involving recombinant human VEGF delivered with various
biomaterials have been tested. PLGA scaffolds delivery systems
showed an increase in vascular density and bone formation in
cranium and calvarial defects (Murphy et al., 2004; Kaigler et al.,
2006), while collagen sponge-delivered VEGF reported similar
results both in calvarial and in mandibular defects (Kleinheinz
et al., 2005; Behr et al., 2012; Jin and Giannobile, 2014). Sustained
release of VEGF has been achieved in different ways, such
as pre-encapsulation in PLGA or gelatin microspheres or co-
precipitation onto BCP, in order to support angiogenesis and
bone formation for a longer period of time (Patel et al., 2008;
De la Riva et al., 2009, 2010; Wernike et al., 2010; Farokhi
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FIGURE 1 | Example strategies for bone regeneration trough Stem Cells recruitment and activation. A scaffold with control release of chemo-attractants
and/or growth factors is grafted into the lesion, endogenous stem cells are attracted and home into the scaffold where they proliferate and differentiate repairing the
tissue.
TABLE 2 | Growth factors and other agents used for local activation and/or mobilization of stem cells in craniofacial and bone regeneration.
Agent Evidence(s) Reference(s)
Bone Morphogenetic
Proteins (BMPs)
Activation of mesenchymal stem cells and osteogenic differentiation. Mechanisms of
action and effects vary between the 15 isoforms of BMPs. The most osteoinductive are
BMP-2, -6, -9, -4, -7.
Bae et al., 2001; Zhao, 2003; Luu et al.,
2007
BMP-2 Knockout mice are lethal; haploinsufficiency causes orofacial clefting in humans. Use
suggested for mandible, cleft, and cranial vault reconstruction.
Zhang and Bradley, 1996; Schliephake
et al., 2008; Sahoo et al., 2011; Chenard
et al., 2012
BMP-4 Knockout mice are lethal; heterozygous null mice exhibit skeletal defects such as
craniofacial malformations and polydactyly. Enhances bone healing when co-expressed
with VEGF by genetically manipulated stem cells. May be detrimental in osseointegration
of oral implants coated with collagen.
Peng et al., 2002; Zhao, 2003; Stadlinger
et al., 2008
BMP-7 Knockout mice are postnatal lethal and show skeletal patterning defects in skull,
hindlimbs, and ribcage. Stimulates periodontal wound healing in an animal model.
Luo et al., 1995; Giannobile et al., 1998;
Springer et al., 2005a
BMP-6 Some evidences show this isoform to be one of the most osteogenic in animal models. Solloway et al., 1998; Kang et al., 2004
Vascular Endothelial
Growth Factor (VEGF)
Delivered with PLGA or collagen scaffolds enhances bone regeneration in cranium,
calvarial and mandibular defects. Sustained release (up to 5 weeks) can be obtained by
pre-encapsulation of VEGF in PLGA, alginate, or gelatin microspheres or, alternatively, by
VEGF co-precipitation onto BCP (Basic Calcium Phosphate).
Murphy et al., 2004; Kleinheinz et al.,
2005; Patel et al., 2008; De la Riva et al.,
2009, 2010; Wernike et al., 2010; Behr
et al., 2012; Farokhi et al., 2013, 2014
VEGF + BMP2 A combination of these two factors showed an increased vascular density during bone
regeneration but no detectable enhancement in bone formation compared to BMP2
alone in animal models of cranial and mandibular defects. This combination is also
capable of facilitating bone marrow stem cells (BMSCs) homing and differentiation.
Young et al., 2009; Zhang et al., 2011;
Ramazanoglu et al., 2013; Zhang et al.,
2014
Platelet-Derived Growth
Factor (PDGF)
Local administration of PDGF in a critical-size calvarial defect has been shown to
increase bone mineralization similarly to VEGF, but less than BMP-2. Use approved for
periodontal repair by FDA. Chemoattractant for Mesenchymal stem cells (MSCs)
Fiedler et al., 2004; Pellegrini et al., 2009;
Phipps et al., 2012; Jin and Giannobile,
2014
SDF-1 Induces extravasation and homing of mesenchymal cells through the CXCR4 receptor.
SDF-1-loaded scaffolds have been studied in fracture healing models and in calvarial
defects with excellent results. Capable of inducing migration, proliferation and activation
of human periodontal ligament stem cells (PLSCs).
Kitaori et al., 2009; Fujio et al., 2011; Li D.
et al., 2011; Du et al., 2012; Ji et al., 2013;
Liu et al., 2014
SDF-1 + BMP2 The combination of SDF-1 + BMP2 increases bone volume in a calvarial defect model
compared to SDF-1 alone
Jin and Giannobile, 2014
Platelet-rich Plasma (PRP) PRP is a concentrate of blood platelets that upon activation releases various growth
factors, including PDGF and VEGF. It can be used to enhance tissue healing, especially
in case of concomitant cell transplantation. Potential use of PRP as a stem cell activator
has been suggested in the case of periodontal regeneration.
Anitua et al., 2008; Chen et al., 2010; Del
Corso et al., 2012; Fekete et al., 2012
Platelet-rich Fibrin (PRF) PRF is a polymeric (fibrin-based) scaffold loaded with PRP that has shown good results
in promoting craniofacial bone regeneration both in preclinical and in clinical setting
Simonpieri et al., 2012; Li et al., 2014
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et al., 2013, 2014). Moreover, combination of VEGF and BMP-
2 showed an increased vascular density during bone regeneration
but no detectable enhancement in bone formation, compared to
BMP-2 alone (Young et al., 2009; Zhang et al., 2011; Ramazanoglu
et al., 2013). Plateled-Derived Growth Factor (PDGF) is another
angiogenetic molecule, involved in maturation of newly-formed
blood vessels, but after the report of its chemoattractive action
on Mesenchymal Stem Cells (MSCs) it has been studied as
a homing factor in bone repair (Fiedler et al., 2004; Phipps
et al., 2012). Local administration of PDGF in a critical-size
calvarial defect has been shown to increase bone mineralization
similarly to VEGF, but less than BMP-2 (Jin and Giannobile,
2014). Notably, Chang et al. demonstrated that gene delivery
of PDGF stimulates repair of oral implant extraction socket
defects in a rat model (Chang et al., 2010) moreover, PDGF
has been approved for periodontal repair by FDA (Pellegrini
et al., 2009). One of the most investigated signaling systems for
extravasation and homing of mesenchymal cells is the SDF1-
CXCR4 axis (Kitaori et al., 2009). It represents the perfect target
for enhancing bone regeneration, as it is involved both in MSCs
and endothelial progenitor cells (EPCs) homing dynamics, thus
working both as osteoinductive and pro-angiogenetic. SDF-1-
loaded scaffolds have been studied in fracture healing models
(Fujio et al., 2011; Li X. et al., 2011) and in cranial defects (Ji
et al., 2013; Liu et al., 2014), with excellent results (Figure 1).
There is also evidence that SDF-1 may induce migration,
proliferation and activation of human periodontal ligament
stem cells (PLSCs; Du et al., 2012). The association of SDF-1
with BMP-2 increases bone volume in a calvarial defect model
compared to SDF-1 alone (Jin and Giannobile, 2014). Another
possible approach is the use of Platelet-Rich Plasma (PRP),
a concentrate of blood platelets that upon activation releases
various growth factors, including PDGF and VEGF (Fekete
et al., 2012), and neurotransmitters that have been shown to be
fundamental for tooth repair in animal model (Baudry et al.,
2015). Nevertheless, its role as activator of endogenous stem cells
is still controversial, this mainly due to problems in standardize
the PRP production protocol (Malhotra et al., 2013); its use
seems, however, more efficient in case of soft tissue healing
or in case of concomitant cell transplantation (Anitua et al.,
2008). In the case of periodontal regeneration, the potential use
of PRP as a stem cell activator has been suggested, but not
yet demonstrated (Chen et al., 2010; Del Corso et al., 2012).
On the other hand, Platelet-Rich Fibrin (PRF), a polymeric
(fibrin based) scaffold loaded with PRP, has shown some very
interesting results in promoting craniofacial bone regeneration
both in preclinical and in clinical setting (Simonpieri et al.,
2012; Li et al., 2014). The use of autologous growth factors
released by platelets could overcome one of the major problems
associated with growth factor-mediated recruitment/activation of
stem cells: the high production costs for recombinant human
growth factors-loaded scaffolds. Other strategies proposed in
order to stimulate the synthesis of growth factors directly at the
site of the defect, such as gene transfer by plasmids, viral vectors
or by genetically modified allogeneic or autologous cells, have
been reviewed by Evans CH and will not be further discussed
(Evans, 2014).
Beyond Growth Factors
Small Molecules and Drugs
As considered in the previous section, the use of growth factors
released at the site of defects to activate endogenous stem cells
constitutes a valid and efficient approach for tissue regeneration,
though it is encumbered by high production costs and short
duration in time. If, on one hand, new preparation methods
promise to decrease the costs of production, on the other hand
new approaches for stem cells recruitment and activation are
under investigation (Mallick and Cox, 2013). Old and new
drugs are now being studied for their effects on bone and
dental healing (Laurencin et al., 2014). Statins are the perfect
example of drugs commonly used for hypercholesterolemia that
have now shown a potential to induce bone formation (Mundy
et al., 1999). The use of simvastatin-loaded scaffolds has been
studied in calvarial defects in a rat model, proving an increase
in bone healing; the mechanism of action seems to involve the
local expression of BMP-2 and HIF-1α recruiting autogenous
osteogenic and angiogenetic stem cells (Yueyi et al., 2013).
AMD-3100 (octahydrochloride hydrate) is a new drug currently
approved in USA (trade name: PlerixaforTM) for hematopoietic
stem cells mobilization in patients that do not respond well
to G-CSF alone. It works as a CXCR4 antagonist (or, more
accurately, as a partial agonist), interfering with the SDF-1-
CXCR4 axis and disrupting stem cell homing, with a primary
effect on HSCs and EPCs (Pitchford et al., 2009). Several works
outlined the positive effect of AMD-3100 administration after
a bone lesion in animal models (Toupadakis et al., 2013) while
Kumar and Ponnazhagan evidenced MSCs mobilization from
bone marrow after AMD-3100 administration, and reported
a significant augmentation of bone growth when it was co-
administrated with IGF-1 (Kumar and Ponnazhagan, 2012).
HSCs mobilization operated by G-CSF has been investigated in
a phase II clinical trial in case of tibial osteotomy: in this study,
the patients who received G-CSF infusion for 3 consecutive days
and 4 h before surgery manifested an improved osseointegration
of the bone graft compared to controls, though no difference
in the quality of the newly formed bone was seen between
the two groups (Marmotti et al., 2013). Local application of
G-CSF with gelatin hydrogel has shown a potential use for bone
regeneration as it contributes to an ideal local environment
for fracture healing (Ishida et al., 2010). FTY720 is a small-
molecule analog of sphingosine-1-phosphate (S1P), that works as
a selective agonist on S1P1 and S1P3-5 receptors; it has proved an
angiogenetic effect of microvasculature and an increase in graft
osseointegration (Petrie Aronin et al., 2010; Sefcik et al., 2011). Its
local delivery with PLGA-scaffolds led to statistically significant
increases in bone volumes in a rat model of critical-size calvarial
defects (Huang et al., 2012). Another small compound, SVAK-
12, which acts as a disruptor of the binding of the E3-ligase
Smurf1 with BMP-2 pathway transducers (namely, Smads -1, -5,
and -8), thus increasing downstream signaling, has been found
to potentiate the transdifferentiation of myoblasts toward an
osteoblastic phenotype in vitro (Kato et al., 2011). In another
study, a single local dose of SVAK-12 enhanced bone-healing in
the presence of endogenous BMPs in an animal model of femoral
fracture (Wong et al., 2013).
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Physical Activation of Endogenous Stem
Cells
Pharmacological means are surely a powerful way to activate
and/or mobilize stem cells, but other strategies are being
developed that do not need the exogenous administration of
substances. Though we are still at a seminal point in this
direction, the idea of pursuing stem cells activation through
physical means is revolutionary. Ultrasounds are mechanical
waves (sound waves) characterized by frequencies higher
than the upper audible limit of the human hearing. The
use of ultrasounds skyrocketed in the last decades both in
diagnostics and in therapy; as for bone healing, the most used
ultrasound-based technique is LIPUS (Low-Intensity Pulsed
Ultrasound Stimulation), which has been tested with various
successes in case of bone fractures and non-unions (Watanabe
et al., 2010; Yang et al., 2010). The biology of ultrasound
effects on bone tissue has been a mystery until very recently,
although the role of mechanical stresses is well-known in
the scientific community since a long time (Carter, 1987);
therefore, today is universally accepted that mechanical forces
are a major determinant of stem cells self-renewal and fate
decision, as their roles have been assessed in embryonic and
mesenchymal stem cells (Li D. et al., 2011). In 2013, Kusuyama
et al. demonstrated how LIPUS influences the multilineage
differentiation of mesenchymal stem and progenitor cells, thus
finding a proof of principle for ultrasound use in bone healing
(Kusuyama et al., 2014). The effects of LIPUS on mesenchymal
stem cells have been also studied with regards to chondrogenic
differentiation (Cui et al., 2006) and osteogenic differentiation
for tooth tissue engineering (Lim et al., 2013) in two separate
in vitro studies. Light, beside the ultrasounds, is another notable
mean for endogenous stem cells recruitment. In particular, in
the study by Arany et al. the use of low-power lasers (LPL)
induced reactive oxygen species (ROS) in a dose-dependent
manner, which in turn activated latent TGF-beta via a specific
methionine residue; light-activated TGF-beta was capable of
differentiating human dental stem cells in vitro, and the results
were confirmed in an in vivo pulp cap model in rat teeth.
Moreover, in TGF-beta-RII-null animals this response to laser
was abolished, confirming a central role for TGF-beta in
dental regeneration (Arany et al., 2014). The last example
of physical stimulus known for its effect on gene expression
and stem cell fate is heat (Fan, 2012). Heat shocks constitute
natural occurring events, which can be easily reproduced under
specific conditions. In a series of experiments, DPSCs have
been shown to be more resistant to heat stress compared to
non-stem cells (Yao et al., 2011), and this paved the way
for a heat-induced activation of DPSCs (Rezai Rad et al.,
2013). However, these experiments were conducted in vitro, and
their relative importance to endogenous stem cells activation
has yet to be evidenced, and thus must be considered only
speculative.
CONCLUSIONS AND FUTURE
PERSPECTIVES
Regenerative medicine is today at a crucial point: we have already
developed effective methods to improve tissue regeneration for
some critical districts of the human body, such as the bones
of the craniofacial complex, but these methods usually require
the use of cells obtained from the same individual or from
another individual (respectively, autologous or allogeneic graft),
that need to be processed ex vivo before the transplant takes
place. These procedures, though effective and increasingly
standardized, expose the graft recipient to the risks already
discussed in the previous sections. The increasing understanding
of the mechanisms that regulate stem cell biology in adult
tissues and their role in tissue healing in physiological and
pathological conditions, along with the better comprehension
of the role of the extracellular matrix in tissue dynamics, laid
the foundations to newer strategies in regenerative medicine
that aim to exploit the hidden potential of endogenous stem
cells, such as growth factor-loaded bioscaffolds. These new
approaches have been developed in order to avoid cell processing
and decrease manufacturing burden, which constitute the main
limitations to the spreading of the cell-based approaches. One
way to reduce consistently the production costs would be the use
of gene delivery strategies, in order to induce the synthesis of the
growth factors directly in the host cells. However, this approach
could become detrimental, as it would suffer from the same
legislative and safety concerns of gene therapy (O’Reilly et al.,
2015). Another critical point is that of the almost complete lack
of any kind of data on human patients for growth factors-based
approaches. More clinical trials are mandatory to assess the real
impact of these techniques on human health, including safety
assessments for the use of known mitogens. As for drug-induced
stem cell activation, on the other hand, though even more
molecules are under pre-clinical investigation (Kochegarov,
2009), the ones that have already proved effective in animal
models should be validated for their safety and efficacy on
humans. In this context, AMD-3100 could be regarded as the
ideal drug to begin the clinical investigation, as it is already
approved for human use, though with a different indication.
Finally, concerning the physical approaches, new rigorous
studies are important to understand whether these techniques
can be really considered for a clinical application, as they would
constitute the easiest and the less invasive way to promote tissue
regeneration.
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